TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/6/22 08:30 | 10/4/22 | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ehrlich Christopher B | CA | D | P | 0 | 0.5700 | 0 | 0 | 0 | 178 | D | |||||||||||||||
9/27/22 08:01 | 9/26/22 | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ehrlich Christopher B | CA | D | P | 10 | 0.5500 | 0 | 19 | 12 | 178 | D | |||||||||||||||
2/22/22 16:59 | 2/14/22 | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ehrlich Christopher B | CA | D | P.m | 13 | 4.40 | 0 | 3 | 2 | 159 | D | |||||||||||||||
2/10/22 17:05 | 2/8/22 | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ehrlich Christopher B | CA | D | P.m | 10 | 4.84 | 0 | 2 | 1 | 156 | D | |||||||||||||||
2/7/22 09:00 | 2/3/22 | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ehrlich Christopher B | CA | D | P.m | 31 | 5.13 | 0 | 6 | 4 | 154 | D | |||||||||||||||
1/31/22 17:50 | 1/27/22 | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ehrlich Christopher B | CA | D | P | 27 | 5.30 | 0 | 5 | 3 | 148 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |